Takeda Pharmaceutical Company Limited v. Mylan, Inc.

COMPLAINT against MYLAN PHARMACEUTICALS, INC, MYLAN, INC. (Filing fee $350, receipt number 2213630), filed by TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC., ANDRX LABS, LLC, TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Summons Mylan, Inc., # 13 Summons Myland Pharmaceuticals, Inc.) (plh) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/10/2012)

2012-01-06

1

Download

Disclosure Statement identifying Takeda Pharmaceutical Company Limited as corporate parent or other affiliate, by TAKEDA PHARMACEUTICAL COMPANY LIMITED. (Hunt, Gary) Modified on 1/13/2012. (plh) Per Attorney this document is removed from public view to be redocketed with corrected disclosure statement. [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/12/2012)

2012-01-12

1

View

Disclosure Statement identifying None as corporate parent and Andrx Corporation, Circa Pharmaceuticals, Inc., Oclassen Pharmaceuticals, Inc., Royce Laboratories, Inc., Schein Pharmaceutical Inc., and Theratech, Inc as subsidiary, by WATSON PHARMACEUTICALS, INC. and Cybear LLC as subsidiary of ANDRX LABS, LLC. (Byrne, Richard) Modified on 1/20/2012 to correctly identify subsidiaries. (ksa) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/13/2012)

2012-01-13

1

View

PATENT/TRADEMARK DOCUMENTS ISSUED. (plh) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/13/2012)

2012-01-13

1

View

Disclosure Statement identifying None as corporate parent or other affiliate, by TAKEDA PHARMACEUTICAL COMPANY LIMITED and identifying Takeda Pharmaceutical Company Limited as corporate parent for TAKEDA PHARMACEUTICALS NORTH AMERICA and TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC. (Hunt, Gary) Modified on 1/18/2012 to add additional docket text. (ksa) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/13/2012)

2012-01-13

1

View

NOTICE that instant civil action has been designated for placement into the United States District Court's Alternative Dispute Resolution program. Parties are directed to fully complete the required 26(f) report, which includes the stipulation of selecting an ADR process. Counsel for plaintiff (or in the case of a removal action, counsel for removing defendant) shall make service of the notice on all parties. (ms) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/19/2012)

2012-01-19

1

View

ANSWER, Affirmative Defenses to 1 Complaint, and COUNTERCLAIM against All Plaintiffs by MYLAN, INC., MYLAN PHARMACEUTICALS, INC. (Attachments: # 1 Exhibit 1) (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

2012-01-23

1

View

Disclosure Statement identifying Mylan Inc. as corporate parent or other affiliate, by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

2012-01-23

1

View

NOTICE of Appearance by Matthew T. Logue on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

2012-01-23

1

View

MOTION for attorney T.O. Kong to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2230844) by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Attachments: # 1 Proposed Order) (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

2012-01-23

1

View

MOTION for attorney Matthew Bresnahan to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2230850) by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Attachments: # 1 Proposed Order) (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

2012-01-23

1

View

NOTICE of Appearance by Arthur H. Stroyd, Jr on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Stroyd, Arthur) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

2012-01-23

1

View

ORDER SCHEDULING INITIAL CASE MANAGEMENT CONFERENCE. The Initial Case Management Conference is scheduled for 03/26/12 at 9:30 AM. The 26(f) Report, Proposed Case Management Order, and Stipulation Selecting ADR Process are due on or before 02/24/12. Signed by Judge Arthur J. Schwab on 01/24/12. (eca) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/24/2012)

2012-01-24

1

View

NOTICE of Appearance by Matthew J. Bresnahan on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Bresnahan, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/25/2012)

2012-01-25

1

View

NOTICE of Appearance by Tung-On Kong on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Kong, Tung-On) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/25/2012)

2012-01-25

1

View

ANSWER to 7 Answer to Complaint, Counterclaim of Mylan, Inc. and Mylan Pharmaceuticals, Inc. by ANDRX LABS, LLC, TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC. (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 02/13/2012)

2012-02-13

1

View

STIPULATION selecting ADR process by ANDRX LABS, LLC, MYLAN PHARMACEUTICALS, INC, MYLAN, INC., TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC. (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 02/24/2012)

2012-02-24

1

View

REPORT of Rule 26(f) Planning Meeting. (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 02/24/2012)

2012-02-24

1

View

Proposed Case Management Order by ANDRX LABS, LLC, MYLAN PHARMACEUTICALS, INC, MYLAN, INC., TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC.. (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 02/24/2012)

2012-02-24

1

View

NOTICE of Appearance by Bryan P. Clark on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Clark, Bryan) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

2012-03-01

1

View

MOTION for attorney Gary E. Hood to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2277401) by ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

2012-03-01

1

View

MOTION for attorney Karen M. Zelle to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2277420) by ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

2012-03-01

1

View

MOTION for attorney Keith J. Grady to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2277428) by ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

2012-03-01

1

View

NOTICE of Appearance by Keith J. Grady on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Grady, Keith) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/02/2012)

2012-03-02

1

View

NOTICE of Appearance by Karen M. Zelle on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Zelle, Karen) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/02/2012)

2012-03-02

1

View

NOTICE of Appearance by Gary E. Hood on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Hood, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/02/2012)

2012-03-02

1

View

MOTION to Reschedule Case Managment Conference by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.. (Attachments: # 1 Proposed Order) (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/06/2012)

2012-03-06

1

View

ORDER RESCHEDULING INITIAL CASE MANAGEMENT CONFERENCE. 27 Motion to Continue Case Management Conference is GRANTED. The Initial Case Management Conference previously scheduled for 03/26/12 at 9:30 AM is hereby RESCHEDULED for 04/11/12 at 9:00 AM before Judge Arthur J. Schwab. The Court notes that the ICMC was scheduled for 03/26/12 by doc. no. 13 on 01/24/12, over 6 weeks ago. Signed by Judge Arthur J. Schwab on 03/07/12. (eca) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/07/2012)

2012-03-07

1

View

REPORT of Rule 26(f) Planning Meeting. (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

Proposed Case Management Order by ANDRX LABS, LLC, MYLAN PHARMACEUTICALS, INC, MYLAN, INC., TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC.. (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

STIPULATION selecting ADR process by ANDRX LABS, LLC, MYLAN PHARMACEUTICALS, INC, MYLAN, INC., TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC. (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

Proposed Order Appointing Special Master On Claim Construction And Summary Judgment by ANDRX LABS, LLC, MYLAN PHARMACEUTICALS, INC, MYLAN, INC., TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC.. (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

MOTION for attorney Kathleen Carr to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2285574) by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.. (Attachments: # 1 Proposed Order) (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

MOTION for attorney David Conlin to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2285594) by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.. (Attachments: # 1 Proposed Order) (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

MOTION to Transfer Case or MOTION to Stay by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Hunt, Gary). Added MOTION on 3/9/2012 (plh). [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

BRIEF in Support re 35 Motion to Transfer Case, filed by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Exhibit A to Memorandum, # 2 Affidavit of Christopher Silva, # 3 Exhibit 1 to Affidavit/Declaration, # 4 Exhibit 2 to Affidavit/Declaration, # 5 Exhibit 3 to Affidavit/Declaration, # 6 Exhibit 4 to Affidavit/Declaration, # 7 Exhibit 5 to Affidavit/Declaration, # 8 Exhibit 6 to Affidavit/Declaration, # 9 Exhibit 7 to Affidavit/Declaration, # 10 Exhibit 8 to Affidavit/Declaration, # 11 Exhibit 9 to Affidavit/Declaration) (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

2012-03-08

1

View

BRIEF in Opposition re 35 Motion to Transfer Case, Motion to Stay, filed by MYLAN PHARMACEUTICALS, INC, MYLAN, INC. (Bresnahan, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/15/2012)

2012-03-15

1

View

AFFIDAVIT in Opposition re 35 MOTION to Transfer Case MOTION to Stay filed by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Bresnahan, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/15/2012)

2012-03-15

1

View

Errata re 37 Brief in Opposition to Motion by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. Reason for Correction: signature. (Stroyd, Arthur) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/16/2012)

2012-03-16

1

View

ORDER granting 35 Motion to Transfer Case; denying as moot 35 Motion to Stay. Signed by Judge Arthur J. Schwab on 3-19-12. (Moschetta, Nicole) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/19/2012)

2012-03-19

1

Download

CASE TRANSFERRED IN from the United States District Court - District of Pennsylvania Western; Case Number: 2:12-cv-00026. Original file certified copy of transfer order and docket entries received. (sjo) (Entered: 03/20/2012)

2012-03-20

1

View

NOTICE OF APPEARANCE by Michael S Sommer on behalf of Mylan pharmaceuticals, inc, Mylan, Inc. (Sommer, Michael) (Entered: 03/20/2012)

2012-03-20

1

View

STANDING ORDER IN RE PILOT PROJECT REGARDING CASE MANAGEMENT TECHNIQUES FOR COMPLEX CIVIL CASES IN THE SOUTHERN DISTRICT OF NEW YORK (See M-10-468 Order filed November 1, 2011). This case is hereby designated for inclusion in the Pilot Project Regarding Case Management Techniques for Complex Civil Cases in the Southern District of New York (the Pilot Project), unless the judge to whom this case is assigned determines otherwise. This case is designated for inclusion in the Pilot Project because it is a class action, an MDL action, or is in one of the following Nature of Suit categories: 160, 245, 315, 355, 365, 385, 410, 830, 840, 850, 893, or 950. The presiding judge in a case that does not otherwise qualify for inclusion in the Pilot Project may nevertheless designate the case for inclusion in the Pilot Project by issuing an order directing that the case be included in the Pilot Project. The description of the Pilot Project, including procedures to be followed, is attached to this Order. (Signed by Judge Loretta A. Preska on 10/31/2011) (sjo) (Entered: 07/06/2012)

2012-03-20

1

View

STANDING ORDER IN RE IMPLEMENTATION OF PATENT PILOT PROGRAM IN THE SOUTHERN DISTRICT OF NEW YORK (See M-10-468 Order filed November 21, 2011). It appearing that the Court has elected to participate in the Pilot Project for Patent Cases established pursuant to Pub L. No. 111-349, 124 Stat. 3674. Therefore, effective November 21, 2011, the Court's participation in the Patent Pilot Project will commence and shall include pro se cases. The Pilot program will be subject to the following procedures: When a designated Pilot judge receives a patent case on initial assignment, no transfer will take place. The designated Pilot judge will notify, by memorandum, the Assignment Committee of the assignment with a copy to the Case Assignment Unit.... (Signed by Judge Loretta A. Preska on 11/21/2011) (sjo) (Entered: 07/06/2012)

2012-03-20

1

View

NOTICE OF CASE ASSIGNMENT to Judge Denise L. Cote. Judge Unassigned is no longer assigned to the case. (pgu) (Entered: 03/28/2012)

2012-03-28

1

View

ORDER OF CONSOLIDATION: that the Clerk of Court shall consolidate the above actions under the docket number of the lead case, No. 12 Civ. 24 (DLC). (Signed by Judge Denise L. Cote on 3/30/2012) Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(tro) (Entered: 04/02/2012)

2012-03-30

1

View

TRANSCRIPT of Proceedings re: CONFERENCE held on 5/7/2012 before Judge Denise L. Cote. Court Reporter/Transcriber: Paula Speer, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/7/2012. Redacted Transcript Deadline set for 6/18/2012. Release of Transcript Restriction set for 8/16/2012.Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(McGuirk, Kelly) (Entered: 05/14/2012)

2012-05-14

1

View

NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 5/7/12 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(McGuirk, Kelly) (Entered: 05/14/2012)

2012-05-14

1

View

TRANSCRIPT of Proceedings re: CONFERENCE held on 3/9/2012 before Judge Denise L. Cote. Court Reporter/Transcriber: Ann Hairston, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/7/2012. Redacted Transcript Deadline set for 6/18/2012. Release of Transcript Restriction set for 8/16/2012.Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(McGuirk, Kelly) (Entered: 05/14/2012)

2012-05-14

1

View

NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 3/9/12 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(McGuirk, Kelly) (Entered: 05/14/2012)

2012-05-14

1

View

TRANSCRIPT of Proceedings re: TELECONFERENCE held on 11/29/2012 before Judge Denise L. Cote. Court Reporter/Transcriber: Denise Richards, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/2/2013. Redacted Transcript Deadline set for 1/10/2013. Release of Transcript Restriction set for 3/8/2013.Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(Rodriguez, Somari) (Entered: 12/05/2012)

2012-12-05

1

View

NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a TELECONFERENCE proceeding held on 11/29/2012 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(Rodriguez, Somari) (Entered: 12/05/2012)

2012-12-05

1

View

TRANSCRIPT of Proceedings re: CONFERENCE held on 3/14/2013 before Judge Denise L. Cote. Court Reporter/Transcriber: William Richards, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/28/2013. Redacted Transcript Deadline set for 6/6/2013. Release of Transcript Restriction set for 8/5/2013.Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(Rodriguez, Somari) (Entered: 05/02/2013)

2013-05-02

1

View

NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 3/14/13 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(Rodriguez, Somari) (Entered: 05/02/2013)

2013-05-02

1

View

ORDER FOR DISMISSAL without prejudice... without costs. (Parties' Stipulation of Dismissal Without Prejudice attached) (Signed by Judge Denise L. Cote on 2/26/2014) Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(gr) (Entered: 02/26/2014)

2014-02-26

1

View

Overview

Parties

Counter Claimant

Mylan pharmaceuticals, inc Follow

Represented By

Mylan, Inc. Follow

Represented By

Plaintiff

Andrx Labs, LLC Follow

Represented By

Takeda Pharmaceutical Company Limited Follow

Represented By

Takeda Global Research and Development Center, Inc. Follow

Represented By

Defendant

Watson Pharmaceuticals, Inc. Follow

Represented By

Takeda Pharmaceuticals North America, Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

PATENT/TRADEMARK DOCUMENTS ISSUED. (plh) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/13/2012)

ANSWER, Affirmative Defenses to 1 Complaint, and COUNTERCLAIM against All Plaintiffs by MYLAN, INC., MYLAN PHARMACEUTICALS, INC. (Attachments: # 1 Exhibit 1) (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

Disclosure Statement identifying Mylan Inc. as corporate parent or other affiliate, by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

NOTICE of Appearance by Matthew T. Logue on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

MOTION for attorney T.O. Kong to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2230844) by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Attachments: # 1 Proposed Order) (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

MOTION for attorney Matthew Bresnahan to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2230850) by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Attachments: # 1 Proposed Order) (Logue, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

NOTICE of Appearance by Arthur H. Stroyd, Jr on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Stroyd, Arthur) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/23/2012)

NOTICE of Appearance by Matthew J. Bresnahan on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Bresnahan, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/25/2012)

NOTICE of Appearance by Tung-On Kong on behalf of MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Kong, Tung-On) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 01/25/2012)

REPORT of Rule 26(f) Planning Meeting. (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 02/24/2012)

NOTICE of Appearance by Bryan P. Clark on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Clark, Bryan) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

MOTION for attorney Gary E. Hood to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2277401) by ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

MOTION for attorney Karen M. Zelle to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2277420) by ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

MOTION for attorney Keith J. Grady to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2277428) by ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/01/2012)

NOTICE of Appearance by Keith J. Grady on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Grady, Keith) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/02/2012)

NOTICE of Appearance by Karen M. Zelle on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Zelle, Karen) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/02/2012)

NOTICE of Appearance by Gary E. Hood on behalf of ANDRX LABS, LLC, WATSON PHARMACEUTICALS, INC.. (Hood, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/02/2012)

MOTION to Reschedule Case Managment Conference by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.. (Attachments: # 1 Proposed Order) (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/06/2012)

REPORT of Rule 26(f) Planning Meeting. (Byrne, Richard) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

MOTION for attorney Kathleen Carr to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2285574) by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.. (Attachments: # 1 Proposed Order) (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

MOTION for attorney David Conlin to Appear Pro Hac Vice, (Filing fee $40, Receipt # 0315-2285594) by TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.. (Attachments: # 1 Proposed Order) (Hunt, Gary) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/08/2012)

BRIEF in Opposition re 35 Motion to Transfer Case, Motion to Stay, filed by MYLAN PHARMACEUTICALS, INC, MYLAN, INC. (Bresnahan, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/15/2012)

AFFIDAVIT in Opposition re 35 MOTION to Transfer Case MOTION to Stay filed by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. (Bresnahan, Matthew) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/15/2012)

Errata re 37 Brief in Opposition to Motion by MYLAN PHARMACEUTICALS, INC, MYLAN, INC.. Reason for Correction: signature. (Stroyd, Arthur) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/16/2012)

ORDER granting 35 Motion to Transfer Case; denying as moot 35 Motion to Stay. Signed by Judge Arthur J. Schwab on 3-19-12. (Moschetta, Nicole) [Transferred from Pennsylvania Western on 3/20/2012.] (Entered: 03/19/2012)

CASE TRANSFERRED IN from the United States District Court - District of Pennsylvania Western; Case Number: 2:12-cv-00026. Original file certified copy of transfer order and docket entries received. (sjo) (Entered: 03/20/2012)

NOTICE OF APPEARANCE by Michael S Sommer on behalf of Mylan pharmaceuticals, inc, Mylan, Inc. (Sommer, Michael) (Entered: 03/20/2012)

NOTICE OF CASE ASSIGNMENT to Judge Denise L. Cote. Judge Unassigned is no longer assigned to the case. (pgu) (Entered: 03/28/2012)

ORDER OF CONSOLIDATION: that the Clerk of Court shall consolidate the above actions under the docket number of the lead case, No. 12 Civ. 24 (DLC). (Signed by Judge Denise L. Cote on 3/30/2012) Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(tro) (Entered: 04/02/2012)

ORDER FOR DISMISSAL without prejudice... without costs. (Parties' Stipulation of Dismissal Without Prejudice attached) (Signed by Judge Denise L. Cote on 2/26/2014) Filed In Associated Cases: 1:12-cv-00024-DLC, 1:12-cv-02038-DLC(gr) (Entered: 02/26/2014)

Track Case Updates

Mylan pharmaceuticals, inc

Mylan, Inc.

Andrx Labs, LLC

Takeda Pharmaceutical Company Limited

Takeda Global Research and Development Center, Inc.

Watson Pharmaceuticals, Inc.

Takeda Pharmaceuticals North America, Inc.